Ich sage "ich"

In der vorliegenden Arbeit untersuche ich verschiedene Funktionen, die das Wort 'Ich' in unserer Sprache einnehmen. In der Alltagssprache sprechen wir in vielen verschiedenen Weisen und Situationen über uns selbst. Dies ist verbunden mit verschiedenen Verwendungsweisen des Pronomens der ersten Person, das verschiedene Rollen in unserer Sprache haben kann. Wittgensteins Spätphilosophie ist bestrebt diese Rollen zu beschreiben. Dazu beobachtet Wittgenstein den Gebrauch der Alltagssprache

Ich sage "ich"

In der vorliegenden Arbeit untersuche ich verschiedene Funktionen, die das Wort 'Ich' in unserer Sprache einnehmen. In der Alltagssprache sprechen wir in vielen verschiedenen Weisen und Situationen über uns selbst. Dies ist verbunden mit verschiedenen Verwendungsweisen des Pronomens der ersten Person, das verschiedene Rollen in unserer Sprache haben kann. Wittgensteins Spätphilosophie ist bestrebt diese Rollen zu beschreiben. Dazu beobachtet Wittgenstein den Gebrauch der Alltagssprache

Procesamiento de señales EEG de un niño con TEA al desarrollar actividades de lectoescritura: determinación de potencia y cronología de eventos

Se presenta el análisis y procesamiento de señales electroencefalográficas (EEG) de un niño de 10 años con Trastorno del Espectro Autista al desarrollar actividades de lectoescritura, en este caso, relacionar en pruebas sucesivas palabras con su imagen representativa, como la palabra manzana con una imagen de una manzana. Una vez adquiridas las muestras, se lleva a cabo un análisis de potencia para cada canal mediante el Teorema de Wiener – Khinchine y posteriormente, mediante la Transformada Wavelet se determinan los momentos en los que hubo mayor actividad en cada electrodo. Con esta información se presenta la cronología de eventos de activación registrada por cada electrodo

Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients The ENDORSE Global Survey

Limited data are available regarding the risk for venous thromboembolism (VIE) and VIE prophylaxis use in hospitalised medically ill patients. We analysed data from the global ENDORSE survey to evaluate VTE risk and prophylaxis use in this population according to diagnosis, baseline characteristics, and country. Data on patient characteristics, VIE risk, and prophylaxis use were abstracted from hospital charts. VTE risk and prophylaxis use were evaluated according to the 2004 American College of Chest Physicians (ACCP) guidelines. Multivariable analysis was performed to identify factors associated with use of ACCP-recommended prophylaxis. Data were evaluated for 37,356 hospitalised medical patients across 32 countries. VIE risk varied according to medical diagnosis, from 31.2% of patients with gastrointestinal/hepatobiliary diseases to 100% of patients with acute heart failure, active noninfectious respiratory disease, or pulmonary infection (global rate, 41.5%). Among those at risk for VTE, ACCP-recommended prophylaxis was used in 24.4% haemorrhagic stroke patients and 40-45% of cardiopulmonary disease patients (global rate, 39.5%). Large differences in prophylaxis use were observed among countries. Markers of disease severity, including central venous catheters, mechanical ventilation, and admission to intensive care units, were strongly associated with use of ACCP-recommended prophylaxis. In conclusion, VIE risk varies according to medical diagnosis. Less than 40% of at-risk hospitalised medical patients receive ACCP-recommended prophylaxis. Prophylaxis use appears to be associated with disease severity rather than medical diagnosis. These data support the necessity to improve implementation of available guidelines for evaluating VIE risk and providing prophylaxis to hospitalised medical patients

Venous Thromboembolism Risk and Prophylaxis in the Acute Care Hospital Setting (ENDORSE Survey) Findings in Surgical Patients

Objective: To evaluate venous thromboembolism (VTE) risk in patients who underwent a major operation, including the use of, and factors influencing, American College of Chest Physicians-recommended types of VTE prophylaxis